This website uses cookies primarily for visitor analytics. Certain pages will ask you to fill in contact details to receive additional information. On these pages you have the option of having the site log your details for future visits. Indicating you want the site to remember your details will place a cookie on your device. To view our full cookie policy, please click here. You can also view it at any time by going to our Contact Us page.

Track & trace solution for pharmaceutical packaging

23 February 2016

EVT has introduced a new track and trace image processing system for the pharmaceutical industry. 

EyeTrace was developed to prevent forged pharmaceutical products from entering the supply chain and guarantees traceability. Visual and safety inspections in the pharmaceutical sector are no longer sufficient – additional safety characteristics are unavoidable today.

In 2011 the EU passed a resolution (2011/62/EU), which states that prescription drugs require a serial number to guarantee traceability. Here, EyeTrace is said to offer a secure solution. The solution makes the inspection of security features on the packaging easy, identifies every package and offers a homogeneous control unit.

The new guideline defines two security features – one for checking authenticity and identification of every single package and one to inspect whether the package has been opened already. This requires a glue dot or perforation to be applied to the packaging. 

With EyeTrace the visual inspection can be simplified, because an industrial camera, together with the EyeVision image processing software, is able to detect more than the human eye.  EyeVision can also read codes – an important feature because the unique identifier for distinct identification is a 2D bar code. 

With the code reader function, EyeTrace is able to read the code of the drugmaker; serial number; a national number for the reimbursement of costs; charge number; and expiration date.

Contact Details and Archive...

Related Articles...

Print this page | E-mail this page